August 27, 2020 article Open access Andexanet versus prothrombin complex concentrates: Differences in reversal of factor Xa inhibitors in in vitro thrombin generation Research and Practice in Thrombosis and Haemostasis DOI: 10.1002/rth2.12418 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 4 stored of 39 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Coagulation assays for assessing the bypassing of factor Xa direct oral anticoagulants using VMX-C001 2026 Research and Practice in Thrombosis and Haemostasis article Medicine Blood Coagulation and Thrombosis Mechanisms Open access 2 citations The Efficacy of Andexanet Alfa for the Reversal of Factor Xa Inhibitors Is Not Influenced by Hemodilution with Different Volume Expanders 2024 Journal of Clinical Medicine article Medicine Blood Coagulation and Thrombosis Mechanisms Open access 0 citations Four-factor Prothrombin Complex Concentrate Use for Bleeding Management in Adult Trauma 2024 Anesthesiology article Medicine Trauma, Hemostasis, Coagulopathy, Resuscitation Open access 8 citations Comparative analysis of andexanet alfa and prothrombin complex concentrate in reversing anticoagulation by rivaroxaban ex vivo 2023 British Journal of Anaesthesia article Medicine Blood Coagulation and Thrombosis Mechanisms Open access 17 citations 4 results References 0